Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HARVARD BIOSCIENCE INC Director's Dealing 2013

Oct 23, 2013

34975_dirs_2013-10-23_ea8093c7-7d79-49c5-9861-95849e77c086.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2013-10-18

Reporting Person: LUSCINSKI SUSAN M (Chief Operating Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-10-18 Common Stock M 47247 $3.18 Acquired 492764 Direct
2013-10-18 Common Stock F 36265 $5.5 Disposed 456499 Direct
2013-10-18 Common Stock M 100000 $1.99 Acquired 556499 Direct
2013-10-18 Common Stock F 65960 $5.5 Disposed 490539 Direct
2013-10-18 Common Stock M 38025 $4.28 Acquired 528564 Direct
2013-10-18 Common Stock F 33377 $5.5 Disposed 495187 Direct
2013-10-18 Common Stock M 12500 $2.98 Acquired 507687 Direct
2013-10-18 Common Stock F 9343 $5.5 Disposed 498344 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-10-18 Stock option (right to buy) $3.18 M 47247 Disposed 2019-05-21 Common Stock, par value $0.01 per share (47247) Direct
2013-10-18 Stock option (right to buy) $1.99 M 100000 Disposed 2018-12-04 Common Stock, par value $0.01 per share (100000) Direct
2013-10-18 Stock option (right to buy) $4.28 M 38025 Disposed 2016-08-09 Common Stock, par value $0.01 per share (38025) Direct
2013-10-18 Stock option (right to buy) $2.98 M 12500 Disposed 2015-05-25 Common Stock, par value $0.01 per share (12500) Direct

Footnotes

F1: Includes (a) a deferred stock award of 16,700 restricted stock units which will vest on Jan 1, 2014; (b) a deferred stock award of 9,374 restricted stock units which vest in equal installments on Jan 1, 2014 and Jan 1, 2015; (c) a deferred stock award of 30,954 restricted stock units which vest in equal installments on Jan 1, 2014, Jan 1, 2015, and Jan 1, 2016; (d) and a deferred stock award of 19,337 restricted stock units which vest in equal installments on Jan 1, 2014, Jan 1, 2015, Jan 1, 2016, and Jan 1, 2017; and (e) 369,152 shares of common stock held by Ms. Luscinski.

F2: Represents the number of shares of common stock that the Reporting Person attested to the ownership thereof in accordance with the Issuer's 2000 Stock Option and Incentive Plan, as amended, in connection with the payment of the option exercise price and related withholding taxes. With respect to each option exercise, the Issuer only delivered the net amount of the option shares (after reducing the option shares by the amount of shares subject to such attestation) to the Reporting Person and such attestation shares were not sold by the Reporting Person or delivered to the Issuer. Nevertheless, the SEC deems such exercise and related attestation to be a disposition of shares for purposes of Section 16(a) of the Securities Exchange Act of 1934.

F3: Represents exercise of stock options granted pursuant to the Issuer's 2000 Stock Option and Incentive Plan, as amended.